因塞特医疗

Incyte Corp EVP Stein Sold 25857 Shares on Dec 1 and 2.

Incyte's 15min chart signals MACD Death Cross and Bollinger Bands expanding downward.

Incyte

Incyte Partners with Winnie Harlow to Raise Awareness of Vitiligo

Incyte's Valuation Under the Spotlight Amid Share Price Momentum

Incyte Appoints Richard Hoffman as Executive Vice President and General Counsel.

Catalyst<ul> <li>Most analysts rate INCY Buy or Strong Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>Net outflows across all fund sizes indicate ongoing selling pressure.</li> <li>Recent Bearish Engulfing pattern suggests a potential downward price bias.</li> <li>Technical indicators show that the market is in a volatile state, and the direction is not clear enough.</li></ul>

Key Factors

Incyte Corporation's Executive Vice President and Chief Medical Officer, Stein Steven H, sold a total of 39,757 shares between December 1 and 2, 2025, at prices ranging from $102.04 to $102.96 per share.Incyte Corporation partnered with model Winnie Harlow to raise awareness of vitiligo, a chronic autoimmune condition, through educational videos and public advocacy.

INCY News